13-deoxytedanolide: structure in first source [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 16040283 |
| MeSH ID | M0363959 |
| Synonym |
|---|
| 13-deoxytedanolide |
| (3r,4s,5s,7r,8r,9e,11s,15r,17r)-3,8-dihydroxy-17-[(s)-hydroxy{(2r,3r)-2-methyl-3-[(1s,2z)-1-methylbut-2-en-1-yl]oxiran-2-yl}methyl]-4-methoxy-5,7,9,11,15-pentamethyloxacyclooctadec-9-ene-2,6,12,16-tetrone (non-preferred name) |
| Q27451661 |
| (3r,4s,5s,7r,8r,9e,11s,15r,17r)-3,8-dihydroxy-17-[(s)-hydroxy-[(2r,3r)-2-methyl-3-[(z,2s)-pent-3-en-2-yl]oxiran-2-yl]methyl]-4-methoxy-5,7,9,11,15-pentamethyl-1-oxacyclooctadec-9-ene-2,6,12,16-tetrone |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (7.69%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (92.31%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| tedanolide | 1999 | 2012 | 18.8 | high | 0 | 0 | 2 | 3 | 1 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|